Is EWTX a good stock to buy? We came across a bullish thesis on Edgewise Therapeutics, Inc. on BioEquity Watch’s Substack. In this article, we will summarize the bulls’ thesis on EWTX. Edgewise Therapeutics, Inc.'s share was trading at $38.83 as of June 23rd.
[caption id="attachment_575379" align="aligncenter" width="750"]Edgewise Therapeutics is positioned as a high-conviction clinical-stage biotech transitioning into a substantially de-risked financial structure following the divestiture of its muscular dystrophy pipeline to Servier for...
Create a free account, or log in to read the full article
No credit card required.
We may use your email to send marketing emails about our services. Click here to read our privacy policy.